Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
0.59%0.67%17.35x1.96x3.71x9.57x11.1x 66.74B
0.6%0.61%26.36x3.98x5.45x16.03x19.87x 53.32B
-.--%-.--%37.26x7.61x12.6x24.05x28.31x 48.12B
3.57%3.65%-42.39x2.38x3.06x9.03x10.54x 38.25B
-.--%-.--%25.06x1.6x3.49x11.87x13.77x 29.85B
-.--%-.--%56.96x4.21x3.39x25.31x27.38x 23.51B
-.--%-.--%-6.24x3.79x8.61x-5.3x-4.97x 21.45B
-.--%0.05%64.96x5.83x6.38x43.91x49.53x 19.97B
-.--%-.--%24.05x3.53x5.15x13.48x18.64x 16.38B
-.--%-.--%-37.77x-6.7x18x-49.29x-56.96x 16.47B
-.--%-.--%-116.91x12764.83x12.56x-89.89x-125.29x 12.4B
-.--%-.--%17.57x - 3.61x13.96x16.3x 11.47B
0.17%0.18%54.98x22.42x33.27x47.06x48.53x 11.02B
-.--%-.--%44.88x - - - - 9.88B
2.69%3.07%12.81x1.14x1.85x7.44x10.05x 6.62B
0.38%0.44%27.25x - 7.29x19.35x23.11x 5.56B
1.6%1.74%14.21x1.26x2.43x6.41x7.67x 5.49B
Average 0.56% 0.61% 12.96x 915.56x 8.18x 6.44x 6.10x 23.32B
Weighted average by Cap. 0.6% 0.64% 14.81x 431.99x 7.16x 10.02x 11.06x
Biopharmaceuticals